Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-30

FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (RISPERIDONE). This action approves the generic product under the ANDA …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)